The above studies show that the expression of TRIB1 can reduce the risk of cardiovascular disease through reducing triglyceride levels, maintaining steady-state phagocytosis and percentages of M2 macrophages, and inhibiting the chemotaxis of inflammatory factors and cardiovascular reconstruction. Here, TRIB1 is linked to cardiovascular disorder.